The role of F18-FDG PET/CT in predicting secondary optimal de-bulking in patients with recurrent ovarian cancer
Author:
Publisher
Elsevier BV
Subject
Oncology,Surgery
Reference31 articles.
1. Cancer screening in the United States, 2012: a review of current American Cancer Society guidelines and current issues in cancer screening;Smith;CA Cancer J. Clin.,2012
2. Clinical value of FDG PET/CT in the diagnosis of suspected recurrent ovarian cancer: is there an impact of FDG PET/CT on patient management?;Bilici;Eur. J. Nucl. Med. Mol. Imaging,2010
3. Surgery in recurrent ovarian cancer: the Arbeitsgemeinschaft Gynaekologische Onkologie (AGO) DESKTOP OVAR trial;Harter;Ann. Surg. Oncol.,2006
4. Secondary cytoreductive surgery in the management of platinum-sensitive recurrent epithelial ovarian cancer;Park;J. Surg. Oncol.,2010
5. Role of secondary cytoreductive surgery in ovarian cancer relapse: who will benefit? A systematic analysis of 240 consecutive patients;Sehouli;J. Surg. Oncol.,2010
Cited by 9 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Tata Memorial Centre Evidence Based Use of Nuclear medicine diagnostic and treatment modalities in cancer;Indian Journal of Cancer;2024-01
2. 68Ga–Prostate-Specific Membrane Antigen PET/CT in Ovarian Tumors;Clinical Nuclear Medicine;2022-11-18
3. PET imaging in ovarian cancer;Nuclear Medicine and Molecular Imaging;2022
4. EANM guideline on the role of 2-[18F]FDG PET/CT in diagnosis, staging, prognostic value, therapy assessment and restaging of ovarian cancer, endorsed by the American College of Nuclear Medicine (ACNM), the Society of Nuclear Medicine and Molecular Imaging (SNMMI) and the International Atomic Energy Agency (IAEA);European Journal of Nuclear Medicine and Molecular Imaging;2021-07-03
5. Secondary cytoreduction followed by chemotherapy versus chemotherapy alone in platinum-sensitive relapsed ovarian cancer (SOC-1): a multicentre, open-label, randomised, phase 3 trial;The Lancet Oncology;2021-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3